SCHEMBL6933387

SCHEMBL6933387

CCCCCCCCC1(Oc2ccccc2)CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP2 P08253 5/20 0.43
MMP9 P14780 5/20 0.43
MMP8 P22894 3/20 0.43
MMP13 P45452 3/20 0.43
MMP3 P08254 2/20 0.43
LTA4H P09960 2/20 0.43
OPRK1 P41145 2/20 0.42
OPRM1 P35372 2/20 0.42
OPRL1 P41146 2/20 0.42
OPRD1 P41143 1/20 0.42
MLNR O43193 1/20 0.41
NR1I2 O75469 1/20 0.41
ESR1 P03372 1/20 0.41
NR3C1 P04150 1/20 0.41
PGR P06401 1/20 0.41
ADRB2 P07550 1/20 0.41
CHRM2 P08172 1/20 0.41
ADRB1 P08588 1/20 0.41
HTR1A P08908 1/20 0.41
ADRA2A P08913 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3880114 1.00 MMP2 (0.43) MMP2MMP9MMP8MMP13MMP3
SCHEMBL1878427 0.79 MMP2 (0.42) MMP2MMP9MMP8MMP13MMP3
SCHEMBL287632 0.79 MMP2 (0.42) MMP2MMP9MMP8MMP13MMP3
SCHEMBL498620 0.79 MMP2 (0.42) MMP2MMP9MMP8MMP13MMP3
SCHEMBL289725 0.79 MMP2 (0.42) MMP2MMP9MMP8MMP13MMP3
SCHEMBL5416450 0.78 MMP2 (0.44) MMP2MMP9MMP8MMP13MMP3
SCHEMBL11499462 0.78 MMP2 (0.44) MMP2MMP9MMP8MMP13MMP3
SCHEMBL7721179 0.78 MMP2 (0.44) MMP2MMP9MMP8MMP13MMP3
SCHEMBL1835994 0.78 NR5A1 (0.49) LTA4HESR1CHRM2ADRA2AADORA3
SCHEMBL9227663 0.78 TDP1 (0.37) MMP2MMP9MMP8MMP13MMP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0852140-B1 METHODS FOR MAKING HARDLY SOLUBLE MEDICINE AMORPHOUS NISSAN CHEMICAL IND LTD (JP) 2003-12-03 EP disclosed
EP-1356807-A2 Method for converting sparingly water-soluble medical substance to amorphous state NISSAN CHEMICAL INDUSTRIES, LIMITED (JP) 2003-10-29 EP disclosed
US-6462093-B1 Method for converting sparingly water-soluble medical substance to amorphous state NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2002-10-08 US disclosed
EP-0510213-B1 MULTILAYERED STRETCHABLE SHRINK FILM ASAHI CHEMICAL IND (JP) 1999-02-03 EP disclosed
EP-0852140-A1 METHODS FOR MAKING HARDLY SOLUBLE MEDICINE AMORPHOUS NISSAN CHEMICAL INDUSTRIES, LIMITED (JP) 1998-07-08 EP disclosed
EP-0510213-A1 MULTILAYERED STRETCHABLE SHRINK FILM Asahi Kasei Kogyo Kabushiki Kaisha (JP) 1992-10-28 EP disclosed